Annual report pursuant to section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Income Statement [Abstract]    
Revenues $ 3,418,371   
Expenses    
Cost of revenues 957,040   
Amortization of patents 1,038,505 8,773
Compensation and related taxes 2,997,053 2,676,462
Consulting fees 901,686 2,042,144
Professional fees 655,202 510,112
General and administrative 544,338 303,471
Total operating expenses 7,093,824 5,540,962
Operating loss from continuing operations (3,675,453) (5,540,962)
Other income (expenses)    
Other income    125,000
Realized loss other than temporary decline - available for sale (38,819) (112,500)
Interest income 1,552 978
Interest expense (1,075) (153)
Total other income (expenses) (38,342) 13,325
Loss from continuing operations before provision for income taxes (3,713,795) (5,527,637)
Provision for income taxes      
Loss from continuing operations (3,713,795) (5,527,637)
Discontinued operations:    
Income (loss) from discontinued operations, net of tax 263,460 (1,410,671)
Net loss (3,450,335) (6,938,308)
Less: Net loss attributable to non-controlling interest    10,496
Net loss attributable to Marathon Patent Group, Inc. $ (3,450,335) $ (6,927,812)
Loss per common share, basic and diluted:    
Loss from continuing operations $ (0.81) $ (1.98)
Loss from discontinued operations $ 0.06 $ (0.51)
Income Loss From Operations Basic And Diluted $ (0.75) $ (2.49)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - Basic and Diluted 4,604,193 2,787,593